USPTO guide
How to respond to a USPTO office action
By Mahish Guru, Co-founder and CEO, PatentAssist.ai
Updated
An office action is the examiner's written decision on your application. Most applications get at least one rejection before they are allowed. To keep the application alive you must file a complete reply on time. This guide covers the deadlines, the rejections you will see most, how to structure the reply, and what to do after a final rejection.
Quick answer
- Deadline: usually 3 months from the mailing date, extendable to 6 months by paying extension fees (35 U.S.C. 133, 37 CFR 1.136(a)).
- The reply: answer every rejection and objection, with a full claim listing if you amend (37 CFR 1.111(b), 1.121(c)).
- Interview: talk to the examiner before you file. It often settles claim language faster than another round of paper.
- After a final: AFCP 2.0 ended on December 14, 2024. Your options are a limited amendment, an RCE, or an appeal.
- If you miss it: the application is abandoned (37 CFR 1.135), but can be revived if the delay was unintentional (37 CFR 1.137).
Non-final and final office actions
The first action on the merits is non-final. In reply you can amend the claims and specification, cancel or add claims, argue, and file declarations, all as of right (37 CFR 1.111).
The second action is normally final. Under MPEP 706.07(a), a second or later action on the merits is made final unless the examiner introduces a new ground of rejection that your amendment did not necessitate and that is not based on an information disclosure statement filed with the fee under 37 CFR 1.17(p). If a final action rests on a new ground you did not cause, say so in the reply and ask for the finality to be withdrawn.
A final action closes prosecution. After it, amendments are entered only within the limits of 37 CFR 1.116, covered below.
The deadline and extension fees
35 U.S.C. 133 gives the applicant 6 months after an action to reply, or a shorter time of at least 30 days set by the Director. 37 CFR 1.134 allows the full 6 months unless the action sets a shorter period. In practice it always does. MPEP 710.02(b) sets a shortened statutory period of 3 months for an action on the merits and 2 months for a restriction or election of species requirement with no action on the merits.
Under 37 CFR 1.136(a) you can extend the shortened period without asking permission, by filing a petition and paying the fee in 37 CFR 1.17(a). The fee depends on the date you file, not on when the period ended, and nothing can carry the reply past 6 months from the action. For a 3-month period the fees are:
| Extension | Reply due | Standard | Small | Micro |
|---|---|---|---|---|
| 1st month | 4 months | $235 | $94 | $47 |
| 2nd month | 5 months | $690 | $276 | $138 |
| 3rd month | 6 months | $1,590 | $636 | $318 |
Fees effective January 19, 2025, as listed on the USPTO fee schedule. Fourth and fifth month extensions ($2,495 and $3,395 standard) are only usable where the period set was shorter than 3 months.
The 2-month rule after a final rejection
A final rejection also sets 3 months, with one difference. If your first reply is filed within 2 months of the final action, the period ends 3 months from the final action or on the date the advisory action is mailed, whichever is later (MPEP 706.07(f)). Extension fees are then counted from that later date. File after 2 months and you lose that protection: if the advisory action arrives after the 3 months, you pay extension fees counted from the 3-month date. Either way, the period cannot run past 6 months from the final action.
Restriction requirements
If the examiner finds more than one independent and distinct invention, or several patentably distinct species, the first action may be a restriction or election requirement with no examination of the merits (35 U.S.C. 121, MPEP 800). Your reply must elect one invention or species, even if you disagree (37 CFR 1.143).
To keep the right to challenge the requirement, elect with traverse and give reasons that distinctly and specifically point out the errors. An election with no statement, or with only a general objection, is treated as an election without traverse (MPEP 818.01(a)). Only a traversed requirement can later be taken to a petition under 37 CFR 1.144, which must be filed no later than appeal. Restriction is petitionable, not appealable. Non-elected inventions can be pursued in a divisional application.
Objections and rejections
A rejection goes to the merits: the claim is unpatentable as written. An objection goes to form, such as a dependent claim that would be allowable but depends on a rejected claim, or a drawing that does not show a claimed feature. The difference matters for review. A rejection that persists can be appealed to the Patent Trial and Appeal Board. An objection can only be reviewed by petition to the Director (MPEP 706.01). Answer both. 37 CFR 1.111(b) lets you ask that objections of form not needed for examining the claims be held in abeyance until allowable subject matter is found.
Common rejections and how to answer them
| Rejection | What it means and how to answer |
|---|---|
| Subject matter eligibility 35 U.S.C. 101; MPEP 2106 | The claim is said to be directed to an abstract idea, law of nature or natural phenomenon without significantly more. Argue the claim is not directed to the exception, or that it integrates it into a practical application, such as a specific improvement to computer functionality. |
| Anticipation 35 U.S.C. 102; MPEP 2131 | One reference is said to disclose every element arranged as claimed. Identify the element the reference does not disclose, or amend to add one the specification supports. A prior disclosure by the inventor may fall under an exception in 102(b)(1), shown by a declaration under 37 CFR 1.130. |
| Obviousness 35 U.S.C. 103; MPEP 2141-2145 | The claim is said to be obvious over one or more references. Attack the factual findings, the stated reason to combine, or the expectation of success, and file evidence of unexpected results or other secondary considerations under 37 CFR 1.132 where you have it. |
| Written description and enablement 35 U.S.C. 112(a); MPEP 2161-2164 | The specification is said not to show possession of the claimed invention, or not to teach how to make and use it without undue experimentation. Cite the passages, figures and examples that support each limitation. |
| Indefiniteness 35 U.S.C. 112(b); MPEP 2171-2173 | A term or phrase does not set out the scope of the claim with reasonable certainty, or lacks antecedent basis. Usually fixed by amendment: correct antecedent basis, replace relative terms, or point to the definition in the specification. |
| Nonstatutory double patenting MPEP 804 | The claims are not patentably distinct from claims in another of your patents or applications. Argue the claims are distinct, or file a terminal disclaimer under 37 CFR 1.321. |
Section 101: the Alice/Mayo framework
Examiners apply the two-step test from Alice and Mayo as set out in MPEP 2106. Step 1 asks whether the claim falls in a statutory category. Step 2A asks whether it recites a judicial exception (prong one) and, if so, whether the claim as a whole integrates it into a practical application (prong two). Only if it does not, Step 2B asks whether the additional elements amount to significantly more than the exception. Most software and AI rejections are won or lost at prong two.
The USPTO's eligibility guidance now sits in MPEP 2103 to 2106.07, with later material listed on its eligibility page: the 2024 AI guidance update (July 17, 2024), a memo to examiners of August 4, 2025, the advance notice of MPEP changes (December 5, 2025) after the Appeals Review Panel decision in Ex parte Desjardins, designated precedential on November 4, 2025, and memos on subject matter eligibility declarations under 37 CFR 1.132 (April 30, 2026 and September 29, 2026). Desjardins treats an improvement to how a machine learning model itself operates as a possible improvement to technology, and warns examiners against reading claims at so high a level of generality that real technical limitations are dismissed as generic computer parts. Tie your argument to the specific technical improvement the specification describes, and cite the guidance by name.
Section 103: Graham and KSR
Obviousness is decided on the Graham v. John Deere factual inquiries: the scope and content of the prior art, the differences between the art and the claim, and the level of ordinary skill (MPEP 2141). After KSR v. Teleflex, the examiner may rely on any of the rationales in MPEP 2143, such as combining known elements by known methods for predictable results, or "obvious to try". But the rejection still needs articulated reasoning with some rational underpinning.
A good 103 response checks each finding: is every claim limitation actually in the cited art, does the stated reason to combine hold up, would the combination change the principle of operation of the primary reference or make it unfit for its purpose, and would a skilled person have expected success? Then add objective evidence where you have it, such as unexpected results, commercial success or long-felt need, by declaration under 37 CFR 1.132. Read the references in full. A free USPTO patent search pulls up cited US patents and publications with their claims.
How to structure the reply
37 CFR 1.111(b) requires a written reply that distinctly and specifically points out the errors in the action and answers every ground of objection and rejection. A general statement that the claims are patentable does not comply. Under 1.111(c), when you amend you must also point out the patentable novelty and show how the amendment avoids the references. A typical reply runs in this order:
- Introduction: application number, examiner, art unit, the date of the action, and any extension of time requested.
- Amendments to the specification: replacement paragraphs, each with an instruction saying where it goes, added text underlined and deleted text struck through (37 CFR 1.121(b)).
- Claim listing: on a separate sheet, every claim ever presented in numerical order, each with a status identifier: (Original), (Currently amended), (Canceled), (Withdrawn), (Previously presented), (New) or (Not entered). Only currently amended claims carry markings: underlining for additions, strike-through for deletions, or double brackets for deleting five or fewer characters (37 CFR 1.121(c)).
- Amendments to the drawings: replacement sheets, if any.
- Remarks: the status of the claims, a summary of any interview, then each objection and rejection in the order of the action. For every amendment, cite the paragraphs that support it. No new matter may be added (35 U.S.C. 132(a)).
- Evidence: declarations under 37 CFR 1.130 or 1.132, where you rely on them.
Keep the remarks narrow. Statements made to get around a reference can limit the claim later through prosecution history estoppel, so argue the limitation that matters and stop there. Amend dependent claims into independent form where the examiner has indicated they are allowable. The same claim drafting habits that avoid 112(b) problems apply here; see how to write patent claims.
Who may sign: since July 20, 2026, applicants and patent owners domiciled outside the United States must be represented by a registered patent practitioner, and their replies must be signed by one (37 CFR 1.31 and 1.33(b)). Juristic entities already needed one.
Examiner interviews
An interview is often the fastest way to learn what claim language the examiner will accept. Request one with the USPTO's Automated Interview Request (AIR) form or form PTOL-413A, and send a short agenda and any proposed claim amendments in advance (MPEP 713.01). Interviews can be held by phone, by video or in person.
- Before the first action, an interview is ordinarily granted only in continuing or substitute applications; in others it is at the examiner's discretion (37 CFR 1.133(a)(2), MPEP 713.02).
- After a final rejection, normally one interview is allowed, and only if the issues can be resolved with nominal further consideration (MPEP 713.09).
- The substance of every interview must be made of record. Put your own summary in the reply (37 CFR 1.133(b), MPEP 713.04).
- An interview does not stop the clock. The reply is still due on the same date.
Options after a final rejection
The After Final Consideration Pilot 2.0, which gave examiners extra time to consider a narrowing amendment after final, ended on December 14, 2024. Requests filed after that date are not accepted. As of October 25, 2026 the USPTO has not announced a replacement. That leaves these routes:
- Amendment after final (37 CFR 1.116): an amendment that only cancels claims or meets a requirement of form already set out in an action may be made. Other amendments may be entered if they put the claims in better form for appeal, or on a showing of good and sufficient reasons why they are necessary and were not presented earlier. Rewriting an allowable dependent claim in independent form is the usual way to get a case allowed at this stage. The examiner replies with an advisory action, and the clock keeps running.
- Request for continued examination (37 CFR 1.114): withdraws finality and reopens prosecution. It must include a submission that meets 37 CFR 1.111, such as an amendment, new arguments or new evidence, and the fee: $1,500 for the first RCE and $2,860 for each later one (standard rate; small entity $600 and $1,144, micro $300 and $572).
- Appeal to the PTAB (37 CFR 41.31): once any claim has been rejected twice, file a notice of appeal within the period for reply, with the $905 fee (standard). The appeal brief is due within 2 months of the notice (37 CFR 41.37(a)) and has no fee. If the examiner answers the brief, a $2,535 forwarding fee is due to send the appeal to the Board.
- Pre-appeal brief conference: filed with the notice of appeal, at no extra fee. A panel of examiners reviews the rejection for clear errors before you write the brief. The arguments may not exceed 5 pages, and no amendment may be filed with the request (MPEP 1204.02). It works best where the examiner has missed a limitation or misread a reference.
- Continuation: a new application filed while the parent is pending, to pursue different claims while the parent goes to appeal or is abandoned.
Abandonment and revival
If no complete reply is filed within the period, as extended, the application is abandoned (37 CFR 1.135(a)). An amendment after final that is not entered does not save it (1.135(b)). A reply that is a bona fide attempt but inadvertently misses something may get a new period to supply the omission (1.135(c)).
An abandoned application can be revived if the delay was unintentional. The petition under 37 CFR 1.137(a) must include the missing reply (an RCE or a continuing application can serve where prosecution was closed), the petition fee, and a statement that the entire delay, from the due date to the filing of a grantable petition, was unintentional. The fee is $2,260 (small $904, micro $452) if the delay is one year or less and $3,000 (small $1,200, micro $600) if it is longer. For petitions filed after August 13, 2026, the USPTO requires an additional explanation of the circumstances when the petition comes more than one year after abandonment, down from two years (Federal Register, June 24, 2026). File promptly once you learn of the abandonment.
Responding to an Indian application instead? See how to respond to a First Examination Report.
Draft the amendments in USPTO format
PatentAssist.ai drafts claims and specifications in USPTO format, and its AI copilot helps you edit them mid-draft, for example to work a narrowing limitation from the description into the claims. Its office action feature supports Indian FERs today. USPTO office action support is coming, so the response itself stays with you or your practitioner.
More USPTO guides
- How to file a provisional patent application (US)
What a US provisional must contain, the USPTO fees, the 12-month deadline under 35 U.S.C. 119(e), and when to skip it.
- USPTO patent fees (2026)
Every USPTO patent fee for large, small and micro entities, from filing to maintenance, with a fee calculator.
- Patent drawing requirements: USPTO, EPO and India
37 CFR 1.84, the EPO rules that replaced Rule 46 EPC, and Indian rule 15, compared side by side.
- How to write patent claims: USPTO, EPO and India
Claim structure and worked examples, then the claim rules and fees at the USPTO, the EPO and the Indian Patent Office, side by side.
USPTO office action response: frequently asked questions
How long do I have to respond to a USPTO office action?
A non-final or final rejection normally sets a shortened statutory period of 3 months (MPEP 710.02(b)). You can extend it month by month under 37 CFR 1.136(a) by paying an extension fee, up to the 6-month maximum in 35 U.S.C. 133. A restriction requirement with no action on the merits sets 2 months, extendable the same way.
What is the difference between a non-final and a final rejection?
After a non-final rejection you can amend and argue as of right under 37 CFR 1.111. A final rejection closes prosecution: amendments after final are entered only if they cancel claims, meet a requirement of form, put claims in better form for appeal, or are shown to be necessary and not earlier presentable (37 CFR 1.116). To keep arguing on the merits you usually file an RCE or appeal.
How much does an extension of time cost at the USPTO?
Since January 19, 2025: $235 for one month, $690 for two and $1,590 for three, at the standard rate. Small entities pay 40% of that and micro entities 20%. Fourth and fifth month extensions cost $2,495 and $3,395, but only reach 6 months in total where the period set was shorter than 3 months.
How do I respond to a 35 U.S.C. 103 obviousness rejection?
Check each factual finding against the references: does the combination really teach every limitation, does the examiner give an articulated reason to combine, and would a skilled person have expected success? Then amend to a feature the art does not suggest, argue the errors limitation by limitation, and add evidence of unexpected results or other objective indicia under 37 CFR 1.132 if you have it (MPEP 2141, 2143 and 2145).
Is AFCP 2.0 still available after a final rejection?
No. The USPTO ended the After Final Consideration Pilot 2.0 on December 14, 2024, and requests filed after that date are not accepted. As of October 2026 no replacement program has been announced. The remaining options are an amendment under 37 CFR 1.116, an interview, an RCE, or a notice of appeal with or without a pre-appeal brief conference request.
Can I revive an application that went abandoned for failure to respond?
Yes, if the delay was unintentional. File a petition under 37 CFR 1.137(a) with the reply, the petition fee and a statement that the entire delay was unintentional. The fee is $2,260 (standard) if the petition is filed within one year of abandonment and $3,000 after that. For petitions filed after August 13, 2026, a delay of more than one year also needs an explanation of the circumstances.
Sources: 35 U.S.C. 133; 37 CFR part 1, sections 1.31, 1.33, 1.111, 1.114, 1.116, 1.121, 1.133, 1.134, 1.135, 1.136, 1.137, 1.143 and 1.144, and 37 CFR 41.31 and 41.37; MPEP sections 706, 710, 713, 818, 1204, 2106, 2141 and 2143; USPTO fee schedule (effective January 19, 2025, revised August 14, 2026); Federal Register, June 24, 2026; Federal Register, March 20, 2026; USPTO AFCP 2.0 notice; USPTO subject matter eligibility guidance. This guide is general information, not legal advice. Have a registered patent attorney or agent review your reply.